Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
68
1.590
Why?
Head and Neck Neoplasms
14
2012
281
1.330
Why?
Carcinoma, Squamous Cell
12
2011
326
0.900
Why?
Neck
7
2018
99
0.730
Why?
Vascular Malformations
3
2010
98
0.680
Why?
Head
5
2018
70
0.640
Why?
Patients
1
2018
47
0.600
Why?
Terminal Care
1
2018
46
0.590
Why?
Hemangioma
3
2018
83
0.570
Why?
Laryngectomy
3
2013
27
0.550
Why?
Flow Cytometry
7
2024
473
0.550
Why?
Attitude to Health
1
2018
190
0.550
Why?
Laryngeal Neoplasms
2
2007
41
0.520
Why?
Quality of Life
3
2012
837
0.480
Why?
Carcinoma, Merkel Cell
4
2016
41
0.480
Why?
Laser Therapy
3
2011
84
0.470
Why?
Laryngeal Diseases
1
2013
12
0.430
Why?
Herpes Simplex
1
2013
21
0.420
Why?
Nuclear Proteins
6
2015
240
0.420
Why?
Parotid Diseases
1
2012
3
0.420
Why?
Neuromuscular Agents
1
2012
7
0.420
Why?
Botulinum Toxins, Type A
1
2012
13
0.410
Why?
Leukoplakia, Oral
1
2011
6
0.390
Why?
Aminolevulinic Acid
1
2011
8
0.390
Why?
Lasers, Dye
1
2011
9
0.390
Why?
Eating
1
2012
158
0.390
Why?
Photosensitizing Agents
1
2011
19
0.390
Why?
Photochemotherapy
1
2011
33
0.380
Why?
Survivors
1
2012
119
0.380
Why?
Female
30
2024
26514
0.370
Why?
Humans
49
2024
49855
0.370
Why?
Middle Aged
21
2024
12254
0.360
Why?
Male
30
2024
25435
0.360
Why?
Photoacoustic Techniques
2
2024
71
0.350
Why?
Cheek
1
2010
9
0.350
Why?
Lip
1
2010
10
0.350
Why?
Neoplastic Cells, Circulating
4
2019
74
0.340
Why?
Facial Neoplasms
1
2010
22
0.340
Why?
Pain
1
2012
374
0.340
Why?
Adult
21
2024
13323
0.340
Why?
Aged
16
2018
9433
0.330
Why?
Receptors, Progesterone
1
2009
63
0.330
Why?
Postoperative Complications
3
2012
1000
0.330
Why?
Lymphatic Vessels
1
2009
53
0.320
Why?
Skin Neoplasms
4
2016
489
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
993
0.300
Why?
Neoplasms
1
2018
1233
0.300
Why?
Surgical Flaps
1
2009
114
0.300
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.300
Why?
Laryngeal Nerves
1
2007
15
0.300
Why?
Factor VII
1
2007
3
0.290
Why?
Melanoma
2
2022
282
0.290
Why?
Erythrocytes
2
2024
83
0.290
Why?
Intracranial Arteriovenous Malformations
1
2007
29
0.280
Why?
Dilatation
2
2017
26
0.270
Why?
Malaria
2
2024
37
0.250
Why?
Adolescent
11
2024
6391
0.250
Why?
Gene Silencing
4
2009
114
0.240
Why?
Disease Models, Animal
3
2016
1448
0.240
Why?
Cell Proliferation
4
2016
999
0.220
Why?
Retrospective Studies
10
2015
6106
0.210
Why?
Melanoma, Experimental
2
2016
40
0.210
Why?
Treatment Outcome
7
2018
5165
0.210
Why?
Muscarinic Agonists
1
2002
9
0.210
Why?
Xerostomia
1
2002
2
0.210
Why?
Immunohistochemistry
8
2014
983
0.210
Why?
Sjogren's Syndrome
1
2002
9
0.200
Why?
Promoter Regions, Genetic
7
2015
467
0.200
Why?
Endoscopy
2
2015
119
0.200
Why?
Thiophenes
1
2002
36
0.200
Why?
Plasmodium yoelii
1
2022
14
0.200
Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
Why?
Quinuclidines
1
2002
40
0.200
Why?
Transcription Factors
2
2015
558
0.190
Why?
Veins
3
2010
71
0.190
Why?
Embolization, Therapeutic
3
2011
85
0.190
Why?
Azepines
3
2016
19
0.190
Why?
Triazoles
3
2016
111
0.170
Why?
Child
10
2012
6838
0.170
Why?
Child, Preschool
8
2012
3871
0.160
Why?
Neoplasm Invasiveness
3
2010
268
0.160
Why?
Mast Cells
1
2018
53
0.160
Why?
Mice
10
2022
5671
0.150
Why?
Ki-67 Antigen
3
2013
57
0.150
Why?
Combined Modality Therapy
4
2018
638
0.150
Why?
Cricoid Cartilage
1
2017
11
0.150
Why?
Estradiol
1
2018
213
0.140
Why?
Trachea
1
2017
52
0.140
Why?
Mice, Nude
5
2016
252
0.140
Why?
Follow-Up Studies
3
2011
2174
0.140
Why?
Infant
7
2018
3564
0.140
Why?
Biopsy
3
2015
591
0.140
Why?
Lasers, Semiconductor
2
2022
10
0.140
Why?
Embolism
1
2016
20
0.130
Why?
Benzoxazoles
1
2016
11
0.130
Why?
Neoplasm Staging
2
2010
748
0.130
Why?
Matrix Metalloproteinase 2
1
2016
58
0.130
Why?
Qualitative Research
1
2018
336
0.130
Why?
Matrix Metalloproteinase 9
1
2016
89
0.130
Why?
Tracheotomy
1
2015
13
0.130
Why?
TOR Serine-Threonine Kinases
1
2016
76
0.130
Why?
Tracheal Stenosis
1
2015
12
0.130
Why?
Aged, 80 and over
6
2015
3131
0.130
Why?
Laryngostenosis
1
2015
11
0.130
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.130
Why?
Larynx
2
2017
30
0.120
Why?
Pyrimidines
1
2016
193
0.120
Why?
Proto-Oncogene Proteins c-myc
1
2014
50
0.120
Why?
Disease Progression
3
2014
822
0.120
Why?
Fluorouracil
2
2004
55
0.120
Why?
Gene Expression Regulation, Neoplastic
3
2015
822
0.110
Why?
Carcinoma
2
2012
139
0.110
Why?
DNA Methylation
5
2009
544
0.110
Why?
Plasmodium falciparum
2
2024
19
0.110
Why?
Breast Neoplasms
2
2015
1180
0.110
Why?
Apoptosis
2
2016
1102
0.110
Why?
Animals
10
2022
13133
0.110
Why?
Mastication
1
2012
5
0.110
Why?
Trismus
1
2012
3
0.100
Why?
DNA, Neoplasm
2
2011
145
0.100
Why?
Cisplatin
2
2004
275
0.100
Why?
Adaptor Proteins, Signal Transducing
3
2009
197
0.100
Why?
Radiotherapy, Adjuvant
1
2012
60
0.100
Why?
Recurrence
2
2011
658
0.100
Why?
Receptors, Cell Surface
1
2013
123
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Cross-Sectional Studies
3
2024
1566
0.100
Why?
Chemoradiotherapy
1
2012
42
0.100
Why?
Endothelium, Lymphatic
1
2011
12
0.100
Why?
Syndrome
1
2012
237
0.100
Why?
Administration, Topical
1
2011
56
0.100
Why?
Epigenesis, Genetic
1
2015
369
0.100
Why?
Antigens, CD
1
2013
218
0.100
Why?
Propranolol
1
2012
78
0.100
Why?
Lymphatic Abnormalities
1
2011
22
0.100
Why?
Immunoenzyme Techniques
4
2016
144
0.100
Why?
Enteral Nutrition
1
2012
147
0.100
Why?
Microtubule-Associated Proteins
1
2011
65
0.100
Why?
Deglutition Disorders
1
2012
75
0.100
Why?
Homeodomain Proteins
1
2011
79
0.090
Why?
Brain Neoplasms
1
2014
282
0.090
Why?
Tumor Suppressor Proteins
1
2011
128
0.090
Why?
Diagnosis, Differential
2
2011
1038
0.090
Why?
Risk Assessment
1
2015
1252
0.090
Why?
Weight Gain
1
2012
232
0.090
Why?
Epigenomics
1
2011
67
0.090
Why?
Xenograft Model Antitumor Assays
3
2016
212
0.090
Why?
Lip Neoplasms
1
2010
3
0.090
Why?
Neoplasm Proteins
2
2003
322
0.090
Why?
Diagnostic Imaging
1
2011
177
0.090
Why?
Neoplastic Stem Cells
1
2011
100
0.090
Why?
Neoplasm Recurrence, Local
2
2019
627
0.090
Why?
Survival Rate
3
2011
904
0.090
Why?
Hospitals, Teaching
1
2010
53
0.090
Why?
Lasers, Solid-State
1
2010
32
0.090
Why?
Melanins
1
2009
27
0.090
Why?
Microsatellite Instability
1
2009
18
0.090
Why?
Neoadjuvant Therapy
1
2011
117
0.090
Why?
Medical Records
1
2010
85
0.080
Why?
Young Adult
3
2024
4013
0.080
Why?
Mouth
1
2010
32
0.080
Why?
Vascular Surgical Procedures
1
2011
164
0.080
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
Why?
Carcinoma, Medullary
1
2009
12
0.080
Why?
Pilot Projects
1
2011
700
0.080
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
Why?
Receptors, Estrogen
1
2009
130
0.080
Why?
Immunotherapy
1
2011
237
0.080
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.080
Why?
Muscle, Smooth, Vascular
1
2009
130
0.080
Why?
Port-Wine Stain
1
2008
14
0.080
Why?
Blotting, Western
3
2016
600
0.080
Why?
Dose-Response Relationship, Drug
1
2011
1354
0.080
Why?
Early Detection of Cancer
2
2022
163
0.070
Why?
Thyroid Neoplasms
1
2009
111
0.070
Why?
Cytokines
1
2011
612
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
201
0.070
Why?
Tumor Cells, Cultured
3
2016
460
0.070
Why?
Practice Guidelines as Topic
1
2010
454
0.070
Why?
Factor VIIa
1
2007
9
0.070
Why?
Jaw Diseases
1
2007
6
0.070
Why?
Infant, Newborn
2
2011
2725
0.070
Why?
Practice Management, Medical
1
2006
10
0.070
Why?
Osteonecrosis
1
2007
34
0.070
Why?
Postoperative Hemorrhage
1
2007
52
0.070
Why?
Tongue
1
2007
38
0.070
Why?
Bone Density Conservation Agents
1
2007
74
0.070
Why?
Otolaryngology
1
2006
56
0.070
Why?
Cell Line, Tumor
3
2015
1387
0.070
Why?
Diphosphonates
1
2007
90
0.070
Why?
Recombinant Proteins
1
2007
488
0.060
Why?
Prospective Studies
1
2011
2341
0.060
Why?
Skin
1
2008
412
0.060
Why?
Mice, Inbred NOD
2
2016
94
0.060
Why?
Cameroon
1
2024
4
0.060
Why?
Mice, SCID
2
2016
173
0.060
Why?
Hemeproteins
1
2024
8
0.060
Why?
Parasitemia
1
2024
8
0.060
Why?
Malaria, Falciparum
1
2024
14
0.060
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
Why?
Neoplasm Metastasis
2
2015
235
0.060
Why?
DNA Repair Enzymes
1
2004
42
0.060
Why?
Ataxia Telangiectasia
1
2004
6
0.060
Why?
ROC Curve
1
2024
224
0.060
Why?
Statistics, Nonparametric
1
2004
193
0.060
Why?
Polymerase Chain Reaction
4
2009
453
0.060
Why?
Genes, p16
1
2003
9
0.060
Why?
Radiotherapy
1
2004
124
0.050
Why?
Lymph Node Excision
1
2004
137
0.050
Why?
Proteoglycans
1
2003
81
0.050
Why?
Magnetic Resonance Angiography
2
2018
72
0.050
Why?
Antigens, Nuclear
2
2013
24
0.050
Why?
Magnetic Resonance Imaging
2
2007
1526
0.050
Why?
Transplantation, Heterologous
2
2013
75
0.050
Why?
Longitudinal Studies
1
2024
693
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
594
0.050
Why?
Sensitivity and Specificity
1
2024
855
0.050
Why?
Membrane Glycoproteins
1
2003
247
0.050
Why?
Double-Blind Method
1
2002
678
0.040
Why?
Survival Analysis
3
2009
669
0.040
Why?
Tryptases
1
2018
4
0.040
Why?
Estrogen Receptor beta
1
2018
54
0.040
Why?
Arkansas
1
2004
1981
0.040
Why?
Estrogen Receptor alpha
1
2018
86
0.040
Why?
Protein Transport
1
2018
183
0.040
Why?
Ultrasonography, Doppler
1
2018
41
0.040
Why?
Biopsy, Fine-Needle
2
2009
108
0.040
Why?
Cadaver
1
2017
96
0.040
Why?
Pressure
1
2017
105
0.040
Why?
Risk Factors
3
2015
3596
0.030
Why?
Serum
1
2016
32
0.030
Why?
Molecular Imaging
1
2016
53
0.030
Why?
Drug Synergism
1
2016
150
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
Why?
Acetylation
1
2015
92
0.030
Why?
Enhancer Elements, Genetic
1
2015
58
0.030
Why?
Keratin-20
1
2014
7
0.030
Why?
Mammography
1
2015
98
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2014
17
0.030
Why?
Drug Therapy, Combination
1
2016
380
0.030
Why?
Prognosis
3
2004
1947
0.030
Why?
Chromatin
1
2015
134
0.030
Why?
Cell Cycle Proteins
1
2015
163
0.030
Why?
HEK293 Cells
1
2014
213
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
32
0.030
Why?
Gene Expression Regulation
1
2018
972
0.030
Why?
Comorbidity
1
2015
607
0.030
Why?
Protein Binding
1
2015
653
0.030
Why?
Down-Regulation
1
2014
347
0.030
Why?
Actins
1
2013
115
0.030
Why?
RNA, Messenger
1
2016
1101
0.030
Why?
Base Sequence
2
2004
644
0.030
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Predictive Value of Tests
1
2014
907
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
Why?
Tissue Culture Techniques
1
2011
37
0.020
Why?
Cell Line
1
2014
1012
0.020
Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
Why?
Gluconates
1
2011
1
0.020
Why?
Gene Expression Profiling
1
2016
1029
0.020
Why?
Graft Survival
1
2011
151
0.020
Why?
Indomethacin
1
2011
38
0.020
Why?
Injections, Subcutaneous
1
2011
53
0.020
Why?
Interleukin-2
1
2011
72
0.020
Why?
Carrier Proteins
2
2003
302
0.020
Why?
Time Factors
2
2007
2889
0.020
Why?
Interleukin-1beta
1
2011
73
0.020
Why?
Cyclophosphamide
1
2011
163
0.020
Why?
Interferon-gamma
1
2011
176
0.020
Why?
Drug Administration Schedule
1
2011
370
0.020
Why?
Glottis
1
2010
32
0.020
Why?
Disease-Free Survival
1
2011
452
0.020
Why?
Endothelial Cells
1
2011
260
0.020
Why?
Sclerotherapy
1
2010
46
0.020
Why?
Calcitonin
1
2009
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2011
389
0.020
Why?
Thyroidectomy
1
2009
59
0.020
Why?
Paraffin Embedding
1
2008
52
0.020
Why?
Mice, Transgenic
1
2009
541
0.020
Why?
Signal Transduction
1
2014
1605
0.020
Why?
Curettage
1
2007
12
0.020
Why?
Dental Care
1
2007
11
0.020
Why?
Mouth Floor
1
2007
5
0.020
Why?
Polyvinyl Alcohol
1
2007
9
0.020
Why?
Hyperbaric Oxygenation
1
2007
14
0.020
Why?
Current Procedural Terminology
1
2006
7
0.020
Why?
Collateral Circulation
1
2007
39
0.020
Why?
Pharyngeal Diseases
1
2007
13
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Cutaneous Fistula
1
2007
14
0.020
Why?
Neck Dissection
1
2007
30
0.020
Why?
Office Visits
1
2006
41
0.020
Why?
Angiography
1
2007
127
0.020
Why?
Fistula
1
2007
26
0.020
Why?
Salvage Therapy
1
2007
136
0.020
Why?
Adrenal Cortex Hormones
1
2007
100
0.020
Why?
Genetic Predisposition to Disease
1
2009
506
0.020
Why?
Imidazoles
1
2007
128
0.020
Why?
Preoperative Care
1
2007
167
0.020
Why?
Ultrasonography
1
2006
428
0.020
Why?
United States
1
2015
4867
0.010
Why?
Guanine
1
2004
40
0.010
Why?
DNA Adducts
1
2004
79
0.010
Why?
Methylation
1
2004
118
0.010
Why?
Syndecans
1
2003
34
0.010
Why?
Syndecan-1
1
2003
72
0.010
Why?
Base Pair Mismatch
1
2003
22
0.010
Why?
Cell Count
1
2003
147
0.010
Why?
Antineoplastic Agents
1
2011
1173
0.010
Why?
DNA Repair
1
2003
185
0.010
Why?
Alcohol Drinking
1
2003
226
0.010
Why?
Molecular Sequence Data
1
2003
791
0.010
Why?
Anti-Bacterial Agents
1
2007
743
0.010
Why?
Smoking
1
2003
505
0.010
Why?
Multiple Myeloma
1
2007
2918
0.010
Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description